You might also like

More about Myeloid-Derived Suppressor Cells and Cancer

• Book details
• Synopsis
• Trending among others

You get 154 loyalty points

Book synopsis

The book starts with an introduction to and history of myeloid-derived suppressor cells (MDSCs), followed by a description of their differentiation, their role in the tumour microenvironment and their therapeutic targeting. It closes with an outlook on future developments. In cancer patients, myelopoiesis is perturbed and instead of generating immunogenic myeloid cells (such as dendritic cells, inflammatory macrophages and granulocytes), there is an increase in highly immature MDSCs. These cells are distributed systemically, resulting in general immunosuppression. They also infiltrate tumours, promoting their progression and metastasis by inhibiting the natural anti-tumour immune response. As these cells also interact with classical anti-neoplastic treatments, they have become major therapeutic targets in the pharmaceutical industry and in oncology research.§

Book details

Book category Books in English Medicine Clinical & internal medicine Diseases & disorders

• Full title: Myeloid-Derived Suppressor Cells and Cancer
• Author: David Escors Murugarren, James Talmadge, Karine Breckpot, Jo van Ginderachter, Grazyna Kochan
• Language: English
• Binding: Paperback
• Number of pages: 102
• EAN: 9783319268194
• ISBN: 3319268198
• ID: 02823805
• Publisher: Springer International Publishing AG
• Weight: 192 g
• Dimensions: 159 × 244 × 12 mm
• Date of publishing: 15. March 2016

Trending among others

---

---

---